| Serial Number | 97594882 |
| Word Mark | IMMUNITYBIO |
| Filing Date | Friday, September 16, 2022 |
| Status | 760 - EX PARTE APPEAL PENDING |
| Status Date | Wednesday, October 1, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Pharmaceutical preparations and substances for the treatment of human viral diseases, animal viral diseases, autoimmune diseases, infectious diseases and cancer for scientific, clinical, medicinal, therapeutic, and diagnostic purposes; pharmaceutical preparations and substances for the prevention, diagnosis, and treatment of human viral diseases, animal viral diseases, autoimmune diseases, infectious diseases and cancer; pharmaceutical and biological preparations for use in targeted immunotherapy for the treatment of human viral diseases, animal viral diseases, autoimmune diseases, infectious diseases and cancer; biological preparations for medical purposes, namely, vaccines for human use and animal use; low-dose chemotherapies, low dose radiation therapies, and personalized neoepitope-targeted therapies, all of the foregoing in the nature of pharmaceutical preparations for medical use for the treatment of human viral diseases, animal viral diseases, autoimmune diseases, infectious diseases, and cancer; anti-cancer preparations; vaccines; biologics, namely, cell-derived preparations, cell therapies, monoclonal antibodies, cytokines, immune modulators, low-dose chemotherapy, low-dose radiation therapy, antibodies, fusion proteins, peptide and cytokine biologics, vaccines, personalized neoepitope-based therapies, cell therapies, and natural killer cell derived preparations, all of the foregoing in the nature of pharmaceutical preparations for clinical, medicinal, therapeutic, and veterinary purposes for the prevention, diagnosis, and treatment of human viral diseases, animal viral diseases, autoimmune diseases, infectious diseases and cancer; kits for clinical, medicinal, therapeutic, and veterinary purposes comprised of clinical medical reagents, cell cultures media for laboratory use, and related printer user instructions sheets |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, October 3, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | Tuesday, January 18, 2022 |
| First Use In Commerce Date | Tuesday, July 19, 2022 |
| Party Name | NANTCELL, INC. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Culver City, CA 90232 |
| Event Date | Event Description |
| Tuesday, September 20, 2022 | NEW APPLICATION ENTERED |
| Monday, October 3, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, June 27, 2023 | ASSIGNED TO EXAMINER |
| Tuesday, June 27, 2023 | NON-FINAL ACTION WRITTEN |
| Tuesday, June 27, 2023 | NON-FINAL ACTION E-MAILED |
| Tuesday, June 27, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, September 27, 2023 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Wednesday, September 27, 2023 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Wednesday, December 20, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, December 20, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, December 21, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, February 5, 2024 | NON-FINAL ACTION WRITTEN |
| Monday, February 5, 2024 | NON-FINAL ACTION E-MAILED |
| Monday, February 5, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, August 5, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, May 6, 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Monday, May 6, 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Monday, August 5, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, August 5, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, April 1, 2025 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Tuesday, April 1, 2025 | FINAL REFUSAL WRITTEN |
| Tuesday, April 1, 2025 | FINAL REFUSAL E-MAILED |
| Wednesday, October 1, 2025 | EXPARTE APPEAL RECEIVED AT TTAB |
| Wednesday, October 8, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, October 8, 2025 | ASSIGNED TO LIE |
| Wednesday, October 8, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, October 1, 2025 | EX PARTE APPEAL-INSTITUTED |
| Thursday, June 26, 2025 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Thursday, June 26, 2025 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Wednesday, October 1, 2025 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Wednesday, October 1, 2025 | JURISDICTION RESTORED TO EXAMINING ATTORNEY |